Invesco Dorsey Wright Industrials Momentum ETF·Financial Services

If you're interested in broad exposure to the Industrials - Broad segment of the equity market, look no further than the Invesco Dorsey Wright Industrials Momentum ETF (PRN), a passively managed exchange traded fund launched on October 12, 2006.

Profound Medical Corp. (TSE: PRN - Get Free Report) Director Dr. Arun Menawat purchased 20,000 shares of Profound Medical stock in a transaction on Friday, March 20th. The shares were purchased at an average cost of C$6.96 per share, with a total value of C$139,200.00. Following the transaction, the director owned 658,660 shares in the company,

All industrial subsectors are significantly overvalued, except transportation. The Invesco Dorsey Wright Industrials Momentum ETF offers superior fundamentals and historical returns versus the sector benchmark XLI. PRN is well-suited for long-term or tactical allocations, though XLI remains preferable for short-term traders due to superior liquidity.

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

The Invesco Dorsey Wright Industrials Momentum ETF (PRN) was launched on October 12, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Industrials - Broad segment of the equity market.
The Invesco Dorsey Wright Industrials Momentum ETF (Fund) is based on the Dorsey Wright Industrials Technical Leaders Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to identify companies that are showing relative strength (momentum), and is composed of at least 30 securities from the NASDAQ US Benchmark Index. Relative strength is the measurement of a security's performance in a given universe over time as compared to the performance of all other securities in that universe. The Fund and the Index are rebalanced and reconstituted quarterly. As of 08/31/2025 the Fund had an overall rating of 4 stars out of 46 funds and was rated 4 stars out of 46 funds, 3 stars out of 42 funds and 4 stars out of 33 funds for the 3-, 5- and 10- year periods, respectively. Source: Morningstar Inc. Ratings are based on a risk-adjusted return measure that accounts for variation in a fund's monthly performance, placing more emphasis on downward variations and rewarding consistent performance. Open-end mutual funds and exchange-traded funds are considered a single population for comparison purposes. Ratings are calculated for funds with at least a three year history. The overall rating is derived from a weighted average of three-, five- and 10-year rating metrics, as applicable, excluding sales charges and including fees and expenses. ©2025 Morningstar Inc. All rights reserved. The information contained herein is proprietary to Morningstar and/or its content providers. It may not be copied or distributed and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not guarantee future results. The top 10% of funds in a category receive five stars, the next 22.5% four stars, the next 35% three stars, the next 22.5% two stars and the bottom 10% one star. Ratings are subject to change monthly. Had fees not been waived and/or expenses reimbursed currently or in the past, the Morningstar rating would have been lower. Ratings for other share classes may differ due to different performance characteristics.
Financial Services
Asset Management
2006-10-12
1.56
Market Peers





